Home Galena Biopharma Receives New Coverage from Analysts at Oppenheimer
 

Keywords :   


Galena Biopharma Receives New Coverage from Analysts at Oppenheimer

2013-11-27 00:45:43| Biotech - Topix.net

The firm set an "outperform" rating and a $6.00 price target on the stock. Oppenheimer's price target suggests a potential upside of 63.49% from the stock's previous close.

Tags: coverage receives analysts oppenheimer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 3A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Post Office sabotaged Horizon probe, says investigator
18.06Atlantic Tropical Weather Outlook
18.06Eastern North Pacific Tropical Weather Outlook
18.06Farm Progress America, June 18, 2024
18.06Farm Progress America, June 18, 2024
More »